Omnicell, Inc. (OMCL)
43.98
+0.49
(+1.13%)
USD |
NASDAQ |
Dec 10, 16:00
43.98
0.00 (0.00%)
After-Hours: 20:00
Omnicell EPS Diluted (Quarterly): 0.119 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| 10X Genomics, Inc. | -0.2189 |
| American Shared Hospital Services | -0.0026 |
| Astrana Health, Inc. | 0.0075 |
| Cryo-Cell International, Inc. | 0.0928 |
| Strata Critical Medical, Inc. | -0.0366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.462M |
| Revenue (Quarterly) | 310.63M |
| Total Expenses (Quarterly) | 305.17M |
| Enterprise Value | 1.933B |
| Gross Profit Margin (Quarterly) | 43.30% |
| Profit Margin (Quarterly) | 1.76% |
| Earnings Yield | 0.97% |
| Operating Earnings Yield | 0.90% |
| Normalized Earnings Yield | 1.016 |